I am extraordinarily pleased to be able to provide two days of outstanding presentations covering the entire scope of what is new and exciting in lymphoma. These sessions should provide a unique format for the exchange of ideas.
New York, NY (PRWEB) September 01, 2016
As the premier forum on the latest advances in lymphoma and myeloma, Lymphoma & Myeloma 2016: An International Congress on Hematologic Malignancies, brings together attendees from nearly 50 countries, for three days of education, from more than 40 expert faculty, global thought leaders and decision makers. Chaired by Drs. Morton Coleman, John P. Leonard, Ruben Niesvizky and Richard R. Furman, all of Weill Cornell Medicine, this Congress features an interdisciplinary approach, special lectures, debates and interactive techniques, all making Lymphoma & Myeloma 2016 the can’t miss opportunity for guidance on recent developments in the basic science, translational medicine and clinical trials in plasma cell disorders.
For the first time ever, the National Lymphoma Rounds Summit, a conference focused on highlights and breaking news in lymphoma, will be held immediately following Lymphoma & Myeloma 2016, on Sunday, October 16 at the Waldorf Astoria Hotel in New York.
Morton Coleman, MD, Chairman of Lymphoma & Myeloma and Program Chair of New York Lymphoma Rounds of the Lymphoma Research Foundation, says, “With the Lymphoma Research Foundation's National Lymphoma Rounds occurring the day after our session on lymphoma, I am extraordinarily pleased to be able to provide two days of outstanding presentations covering the entire scope of what is new and exciting in lymphoma. These sessions should be valuable to both researchers and clinicians, and should provide a unique format for the exchange of ideas.”
Hosted by the Lymphoma Research Foundation, The National Lymphoma Summit provides a forum for healthcare professionals to discuss actual lymphoma cases via an interactive and collaborative format. Attendees will network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma.
“I am very excited that the Lymphoma Research Foundation is collaborating with us as part of the Lymphoma & Myeloma 2016 meeting, says John P. Leonard, MD, Co-Chair Lymphoma & Myeloma and Past Chairman, Lymphoma Research Foundation Scientific Committee. “The Lymphoma Rounds program is an exciting addition to our sessions, and will no doubt be a great venue for community physicians and lymphoma specialists alike to discuss both routine patient management options and challenging cases.”
Both conferences will be held at the Waldorf Astoria Hotel in NYC, October 13-16, 2016. Visit http://www.lymphomaandmyeloma.com for more information.
About Imedex®
Imedex is the industry leader in developing and delivering independent, accredited health care education. Our programs, specializing in oncology, hematology, and gastroenterology, are provided through live events around the world, as well as effective online educational opportunities for on-the-go healthcare providers.
With high-quality scientific programming translating the latest research into clinically-relevant information, our activities address the needs of healthcare professionals inundated by information through exceptional organization and outstanding educational value, with a proven sustained impact on patient care.
Since 2001, our global footprint has provided over 50,000 E-learning experiences annually, and our live conferences have interfaced with more than 100,000 attendees from over 100 countries, including the United States, Europe and Asia.
At Imedex, education is the best medicine®. For more information on Imedex, visit us online at http://www.imedex.com or on our e-learning center at http://elc.imedex.com.
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation's largest non-profit organization devoted exclusively to funding innovative lymphoma research and providing people with lymphoma and healthcare professionals with up-to-date information about this type of cancer. LRF's mission is to eradicate lymphoma and serve those touched by this disease. To date, LRF has funded nearly $58 million in lymphoma-specific research. For additional information on the Lymphoma Research Foundation research and education programs and patient services please visit http://www.lymphoma.org.
###